Trademark: 86192588
Word
APTWIND
Status
Dead
Status Code
606
Status Date
Monday, September 19, 2016
Serial Number
86192588
Mark Type
4000
Filing Date
Thursday, February 13, 2014
Published for Opposition
Tuesday, June 24, 2014
Abandoned Date
Monday, September 19, 2016

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; (Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; (Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
The wording "APTWIND" has no meaning in a foreign language.

Trademark Events
Sep 19, 2016
Abandonment Notice Mailed - No Use Statement Filed
Sep 19, 2016
Abandonment - No Use Statement Filed
Mar 18, 2016
Notice Of Approval Of Extension Request E-Mailed
Mar 17, 2016
Extension 3 Granted
Feb 11, 2016
Extension 3 Filed
Mar 14, 2016
Case Assigned To Intent To Use Paralegal
Feb 11, 2016
Teas Extension Received
Jul 25, 2015
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2015
Extension 2 Granted
Jun 30, 2015
Extension 2 Filed
Jul 24, 2015
Case Assigned To Intent To Use Paralegal
Jun 30, 2015
Teas Extension Received
Jun 22, 2015
Teas Change Of Correspondence Received
Jan 17, 2015
Notice Of Approval Of Extension Request E-Mailed
Jan 15, 2015
Extension 1 Granted
Jan 15, 2015
Extension 1 Filed
Jan 15, 2015
Teas Extension Received
Aug 19, 2014
Noa E-Mailed - Sou Required From Applicant
Jun 24, 2014
Official Gazette Publication Confirmation E-Mailed
Jun 24, 2014
Published For Opposition
Jun 4, 2014
Notification Of Notice Of Publication E-Mailed
May 21, 2014
Law Office Publication Review Completed
May 21, 2014
Assigned To Lie
May 8, 2014
Approved For Pub - Principal Register
May 8, 2014
Notification Of Letter Of Suspension E-Mailed
May 8, 2014
Letter Of Suspension E-Mailed
May 8, 2014
Suspension Letter Written
May 8, 2014
Assigned To Examiner
Feb 26, 2014
New Application Office Supplied Data Entered In Tram
Feb 17, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24